Articles | Volume 6, issue 6
https://doi.org/10.5194/jbji-6-199-2021
https://doi.org/10.5194/jbji-6-199-2021
Letter
 | 
27 May 2021
Letter |  | 27 May 2021

Comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)

Martin McNally

Viewed

Total article views: 1,059 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
765 246 48 1,059 46 47
  • HTML: 765
  • PDF: 246
  • XML: 48
  • Total: 1,059
  • BibTeX: 46
  • EndNote: 47
Views and downloads (calculated since 27 May 2021)
Cumulative views and downloads (calculated since 27 May 2021)

Viewed (geographical distribution)

Total article views: 993 (including HTML, PDF, and XML) Thereof 993 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 23 Nov 2024
Short summary
This paper provides further evidence that treatment of osteomyelitis by serial debridement without the use of local antimicrobials has high recurrence rates (20 %–30 %). The addition of bioglass did not improve this compared to using bone graft alone. Additional systemic antibiotic was required in many cases, increasing the risk of antimicrobial resistance. Recent series of single-stage surgery with local antibiotic delivery have reported better outcomes.